METROPOLITAN LIFE INSURANCE CO/NY - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$15,103
+35.4%
1,0780.0%0.00%0.0%
Q2 2023$11,157
-88.1%
1,078
-80.6%
0.00%0.0%
Q3 2021$93,570
-21.1%
5,563
-8.7%
0.00%
-50.0%
Q1 2021$118,653
+8.1%
6,0910.0%0.00%0.0%
Q4 2020$109,760
-31.0%
6,0910.0%0.00%
-33.3%
Q2 2020$159,097
-7.6%
6,091
-15.7%
0.00%0.0%
Q3 2019$172,2197,2270.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders